National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

sevoflurane
A fluorinated isopropyl ether with general anesthetic activity. Although the mechanism of action has not been fully elucidated, sevoflurane may interfere with the release and re-uptake of neurotransmitters at post-synaptic terminals, and/or alter ionic conductance following receptor activation by a neurotransmitter. This agent may also interact directly with the lipid matrix of neuronal membranes, thereby affecting gating properties of ion channels. In addition, sevoflurane may activate gamma-aminobutyric acid (GABA) receptors, hyperpolarizing cell membranes and resulting in a general anesthetic effect, a decrease in myocardial contractility and mean arterial pressure, and an increased respiratory rate. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Ultane
Chemical structure names:
  • 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
  • Ether, Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl-



Previous:serine protease inhibitor WX-671, serine/threonine kinase inhibitor XL418, Seromycin, Serophene, sertraline hydrochloride
Next:shark cartilage, shark cartilage extract AE-941, sialyl LewisÂȘ-keyhole limpet hemocyanin conjugate vaccine, Sigosix, sildenafil citrate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov